BEMLAYO and DESIGN
"BEMLAYO and DESIGN" is a figurative mark owned by Eli Lilly and Company, filed at the CIPO on January 15, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).
- Status
- Filed
- Since October 1, 2026
- Filed
- January 15, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2450075
- Registration no.
- Not yet
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Figurative mark
- 1 class
Who owns BEMLAYO and DESIGN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Eli Lilly and Company
LLY · United States
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services BEMLAYO and DESIGN is filed for, grouped by Nice class.
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and disorders and musculoskeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, eczema, acne, rosacea, ichthyosis, vitiligo, uticaria and alopecia areata, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes and obesity, and hormonal diseases, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, inflammatory muscle diseases and disorders, anti-inflammatory preparations, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic diseases and disorders, namely, diabetes, gout, arthritis and anemia, obesity, hyperlipidemia, insulin resistance and metabolic syndrome, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, amyotrophic lateral sclerosis (ALS), encephalitis, meningitis, muscular dystrophy, myasthenia gravis, dystonia, epilepsy, seizures, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.
What has happened so far
Steps recorded by the CIPO, newest first.
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Acceptable Goods or Services
- Formalized
- Created
- Filed
About BEMLAYO and DESIGN
Who owns the trademark "BEMLAYO and DESIGN"?
The CIPO trademark "BEMLAYO and DESIGN" (application 2450075) is owned by Eli Lilly and Company.
What is the status of "BEMLAYO and DESIGN"?
Its status at the CIPO is: filed.
Get this data via the API
Everything on this page comes from the Signa API. Pull BEMLAYO and DESIGN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deee9-8cbd-7181-a090-f003bc7bc696
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deee9-8cbd-7181-a090-f003bc7bc696",
"object": "trademark",
"mark_text": "BEMLAYO and DESIGN",
"status": {
"primary": "pending",
"stage": "filed"
},
"office_code": "CA",
"application_number": "2450075",
"filing_date": "2026-01-15",
"nice_classes": [
5
],
"owners": [
{
"name": "Eli Lilly and Company",
"entity_id": "ent_019f286c-97ee-774b-84b5-7d5dc09e0b99"
}
]
}